Novo Nordisk gets USFDA for use of Victoza to treat type 2 diabetes in pediatric patients Meghna A Singhania18 Jun 2019 4:07 PM ISTUS The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with...
Novo Nordisk wins EU panel's backing for key diabetes drug Ruby Khatun Khatun18 Dec 2017 10:30 AM ISTCOPENHAGEN: Danish drugmaker Novo Nordisk came closer to winning European approval for diabetes drug Ozempic, it's biggest growth prospect when a...
FDA approves Novo Nordisk diabetes drug Ozempic Ruby Khatun Khatun6 Dec 2017 10:30 AM ISTThe U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated battle with Eli...
FDA acts to encourage generic competition for complex drugs Ruby Khatun Khatun4 Oct 2017 10:46 AM ISTTRENTON, N.J.: The U.S. Food and Drug Administration (FDA) is opening a new front in its efforts to reduce high drug prices by encouraging the...
Novo Nordisk settles US probe over diabetes drug for nearly 58.7 million dollar Ruby Khatun Khatun7 Sept 2017 10:48 AM ISTNovo Nordisk will pay nearly $58.7 million to resolve claims the drugmaker's sales staff downplayed the importance of U.S. Food and Drug...
